BRICS Diagnostic and Monitoring Devices Market Size and Forecast by Offering, Technology, Clinical Application, Distribution Channel, and End User: 2019-2033

  Dec 2025   | Format: PDF DataSheet |   Pages: 160+ | Type: Niche Industry Report |    Authors: Mahesh Y (Manager)  

 

BRICS Diagnostic and Monitoring Devices Market Outlook

  • In 2024, the market in BRICS stood at USD 37.95 billion, showing a year-over-year growth rate of 9.9%.
  • By 2033, the BRICS Diagnostic and Monitoring Devices Market will attain USD 78.09 billion, with a projected CAGR of 8.7% across the forecast window.
  • DataCube Research Report (Nov 2025): This analysis uses 2024 as the actual year, 2025 as the estimated year, and calculates CAGR for the 2025-2033 period.

Industry Assessment Overview

Industry Findings: Expanding public health and diagnostics access mandates — especially in lower-income member countries — are creating a rising collective demand for affordable, scalable diagnostic and monitoring solutions. The World Health Organization’s 2023 global resolution on diagnostics access (WHA76.5) has galvanized multiple BRICS governments to expand lab networks and decentralized diagnostic capacity (May-2023). This macro-level push is reshaping purchasing patterns: from high-end niche instruments to robust, cost-efficient point-of-care and IVD consumables suited for wide population coverage, pressuring vendors to balance reliability with cost sensitivity.

Industry Progression: In recent years, national regulatory bodies across several BRICS countries have initiated post-market surveillance and harmonization efforts to support large-scale device rollouts. For example, regulatory data published by National Medical Products Administration (NMPA) in China – part of BRICS – highlighted in 2024 a sharp increase in device registrations and renewals (+7.5% vs. 2023), signalling both backlog clearance and new device influx into the bloc’s largest market (2024 summary report). That trend supports supply-chain stabilization across BRICS and opens export-import flows for diagnostics and monitoring devices within the bloc.

Industry Player Insights: The industry innovation pulse in BRICS is driven by Mindray, Siemens Healthineers, Roche Diagnostics, and GE HealthCare etc. Mindray’s strong 2024–2025 revenue growth across APAC and BRICS-linked deployments underscores its cost-competitive positioning. Meanwhile, Siemens and Roche continue leveraging global scale and regulatory experience to supply centralized and regional labs. This vendor mix — combining volume-oriented and premium global suppliers — strengthens BRICS procurement flexibility and supports both high-volume IVD throughput and advanced monitoring infrastructure.

*Research Methodology: This report is based on DataCube’s proprietary 3-stage forecasting model, combining primary research, secondary data triangulation, and expert validation. [Learn more]

Market Scope Framework

Offering

  • Diagnostic Instruments (Lab Analyzers)
  • Point-of-Care Devices
  • Patient Monitoring Systems
  • Imaging Systems
  • Wearable & Consumer Monitoring Devices
  • In Vitro Diagnostics Consumables & Reagents
  • Implantable Monitoring Devices

Technology

  • Imaging-Based Modalities
  • Biochemical Assay-Based Devices
  • Molecular Diagnostics Hardware
  • Electrochemical & Biosensing Devices
  • Optical & Spectroscopic Systems
  • Physiological Monitoring Devices
  • Wearable / Wireless Monitoring Hardware

Clinical Application

  • Cardiovascular Diagnostics & Monitoring
  • Infectious Disease Diagnostics
  • Oncology Diagnostics
  • Metabolic & Endocrine Diagnostics
  • Neurology Monitoring
  • Respiratory Diagnostics & Monitoring
  • Maternal & Neonatal Monitoring
  • General Health & Wellness / Multispecialty

Distribution Channel

  • Direct Sales
  • Distributor / Dealer Channel
  • Group Purchasing Organizations (GPOs) / Buying Consortia
  • E-commerce & Retail Marketplaces

End User

  • Hospitals & Acute Care Facilities
  • Clinical & Reference Laboratories
  • Ambulatory & Physician Clinics
  • Pharmacies & Retail Health Clinics
  • Home Care / Direct-to-Consumer
  • Research & Academic Institutions

Countries Covered

  • Brazil
  • Russia
  • India
  • China
  • South Africa
×

Request Sample

CAPTCHA Refresh